760 filings
25-NSE
The Nasdaq Stock Market LLC
21 Mar 24
Exchange delisting
2:23pm
8-K
DMKPQ
DMK Pharmaceuticals Corp
7 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:19pm
8-K
DMKPQ
DMK Pharmaceuticals Corp
5 Feb 24
Bankruptcy or Receivership
9:00am
8-K
DMKPQ
DMK Pharmaceuticals Corp
31 Jan 24
Submission of Matters to a Vote of Security Holders
5:17pm
DEFA14A
DMKPQ
DMK Pharmaceuticals Corp
23 Jan 24
Additional proxy soliciting materials
5:23pm
8-K
5b34o2vhqf1i5tvf wf
23 Jan 24
Material Modifications to Rights of Security Holders
5:22pm
DEFA14A
28s6wb v7zr
3 Jan 24
Additional proxy soliciting materials
5:03pm
8-K
un5e7k
3 Jan 24
Submission of Matters to a Vote of Security Holders
5:02pm
8-K
ysflfl8 e2o9
3 Jan 24
Regulation FD Disclosure
5:00pm
8-K
5ot2xj6blf
21 Dec 23
Termination of a Material Definitive Agreement
12:31pm
DEFA14A
3zsn v7jnks4zf
4 Dec 23
Additional proxy soliciting materials
4:47pm
8-K
7hcpf
4 Dec 23
Submission of Matters to a Vote of Security Holders
4:45pm
8-K
97fo9
28 Nov 23
DMK Pharmaceuticals Regains Full Rights from US WorldMeds for SYMJEPI® and Provides Corporate Update
4:41pm
DEFA14A
s748j2enc4r24 5h
15 Nov 23
Additional proxy soliciting materials
4:39pm
DEFA14A
0bwyt
15 Nov 23
Additional proxy soliciting materials
4:20pm
8-K
x3rm78 ufm
15 Nov 23
Submission of Matters to a Vote of Security Holders
4:11pm
DEFA14A
ehrpu5 8uswlzcegyk9
15 Nov 23
Additional proxy soliciting materials
4:06pm
8-K
fyo acsqzd5uux2s3q
14 Nov 23
DMK Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
3:57pm
8-K
u6s15h l7okmu8x
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm